Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Gyre Therapeutics (GYRE) Interest Coverage Ratio (2020 - 2024)

Gyre Therapeutics (GYRE) has disclosed Interest Coverage Ratio for 9 consecutive years, with 25.62 as the latest value for Q1 2024.

  • On a quarterly basis, Interest Coverage Ratio rose 147.23% to 25.62 in Q1 2024 year-over-year; TTM through Dec 2024 was 51.31, a 161.99% increase, with the full-year FY2023 number at 25.92, changed N/A from a year prior.
  • Interest Coverage Ratio was 25.62 for Q1 2024 at Gyre Therapeutics, up from 10.36 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 25.62 in Q1 2024 to a low of 376.82 in Q4 2020.
  • A 3-year average of 113.61 and a median of 10.36 in 2023 define the central range for Interest Coverage Ratio.
  • Biggest YoY gain for Interest Coverage Ratio was 147.23% in 2024; the steepest drop was 147.23% in 2024.
  • Gyre Therapeutics' Interest Coverage Ratio stood at 376.82 in 2020, then skyrocketed by 102.75% to 10.36 in 2023, then soared by 147.23% to 25.62 in 2024.
  • Per Business Quant, the three most recent readings for GYRE's Interest Coverage Ratio are 25.62 (Q1 2024), 10.36 (Q1 2023), and 376.82 (Q4 2020).